Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure

Chagas cardiomyopathy (CC), caused by the protozoan <i>Trypanosoma cruzi</i>, is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 20...

Full description

Bibliographic Details
Main Authors: Isis G. Montalvo-Ocotoxtle, Gustavo Rojas-Velasco, Olivia Rodríguez-Morales, Minerva Arce-Fonseca, Luis A. Baeza-Herrera, Arturo Arzate-Ramírez, Gabriela Meléndez-Ramírez, Daniel Manzur-Sandoval, Mayra L. Lara-Romero, Antonio Reyes-Ortega, Patricia Espinosa-González, Erika Palacios-Rosas
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/24/7262
_version_ 1797457061572771840
author Isis G. Montalvo-Ocotoxtle
Gustavo Rojas-Velasco
Olivia Rodríguez-Morales
Minerva Arce-Fonseca
Luis A. Baeza-Herrera
Arturo Arzate-Ramírez
Gabriela Meléndez-Ramírez
Daniel Manzur-Sandoval
Mayra L. Lara-Romero
Antonio Reyes-Ortega
Patricia Espinosa-González
Erika Palacios-Rosas
author_facet Isis G. Montalvo-Ocotoxtle
Gustavo Rojas-Velasco
Olivia Rodríguez-Morales
Minerva Arce-Fonseca
Luis A. Baeza-Herrera
Arturo Arzate-Ramírez
Gabriela Meléndez-Ramírez
Daniel Manzur-Sandoval
Mayra L. Lara-Romero
Antonio Reyes-Ortega
Patricia Espinosa-González
Erika Palacios-Rosas
author_sort Isis G. Montalvo-Ocotoxtle
collection DOAJ
description Chagas cardiomyopathy (CC), caused by the protozoan <i>Trypanosoma cruzi</i>, is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 200,000 deaths by 2025. The World Health Organization (WHO) considers Chagas disease (CD) as a Neglected Tropical Disease (NTD), which must be acknowledged and detected in time, as it remains a clinical and diagnostic challenge in both endemic and non-endemic regions and at different levels of care. The literature on CC was analyzed by searching different databases (Medline, Cochrane Central, EMBASE, PubMed, Google Scholar, EBSCO) from 1968 until October 2022. Multicenter and bioinformatics trials, systematic and bibliographic reviews, international guidelines, and clinical cases were included. The reference lists of the included papers were checked. No linguistic restrictions or study designs were applied. This review is intended to address the current incidence and prevalence of CD and to identify the main pathogenic mechanisms, clinical presentation, and diagnosis of CC.
first_indexed 2024-03-09T16:16:47Z
format Article
id doaj.art-5afb0c14e784422e98a2fcd7d93effcc
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T16:16:47Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-5afb0c14e784422e98a2fcd7d93effcc2023-11-24T15:42:31ZengMDPI AGJournal of Clinical Medicine2077-03832022-12-011124726210.3390/jcm11247262Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart FailureIsis G. Montalvo-Ocotoxtle0Gustavo Rojas-Velasco1Olivia Rodríguez-Morales2Minerva Arce-Fonseca3Luis A. Baeza-Herrera4Arturo Arzate-Ramírez5Gabriela Meléndez-Ramírez6Daniel Manzur-Sandoval7Mayra L. Lara-Romero8Antonio Reyes-Ortega9Patricia Espinosa-González10Erika Palacios-Rosas11Cardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoDepartment of Molecular Biology, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoDepartment of Molecular Biology, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoMagnetic Resonance Imaging Department, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoAcademic Department of Health Sciences, School of Sciences, Universidad de las Américas Puebla, Ex Hacienda Sta. Catarina Mártir S/N. San Andrés Cholula, Puebla 72810, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoCardiovascular Critical Care Unit, National Institute of Cardiology “Ignacio Chávez”, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, MexicoAcademic Department of Health Sciences, School of Sciences, Universidad de las Américas Puebla, Ex Hacienda Sta. Catarina Mártir S/N. San Andrés Cholula, Puebla 72810, MexicoChagas cardiomyopathy (CC), caused by the protozoan <i>Trypanosoma cruzi</i>, is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 200,000 deaths by 2025. The World Health Organization (WHO) considers Chagas disease (CD) as a Neglected Tropical Disease (NTD), which must be acknowledged and detected in time, as it remains a clinical and diagnostic challenge in both endemic and non-endemic regions and at different levels of care. The literature on CC was analyzed by searching different databases (Medline, Cochrane Central, EMBASE, PubMed, Google Scholar, EBSCO) from 1968 until October 2022. Multicenter and bioinformatics trials, systematic and bibliographic reviews, international guidelines, and clinical cases were included. The reference lists of the included papers were checked. No linguistic restrictions or study designs were applied. This review is intended to address the current incidence and prevalence of CD and to identify the main pathogenic mechanisms, clinical presentation, and diagnosis of CC.https://www.mdpi.com/2077-0383/11/24/7262Chagas diseaseChagas cardiomyopathy (CC)chronic Chagas cardiomyopathy (CCC)myocarditisheart failure
spellingShingle Isis G. Montalvo-Ocotoxtle
Gustavo Rojas-Velasco
Olivia Rodríguez-Morales
Minerva Arce-Fonseca
Luis A. Baeza-Herrera
Arturo Arzate-Ramírez
Gabriela Meléndez-Ramírez
Daniel Manzur-Sandoval
Mayra L. Lara-Romero
Antonio Reyes-Ortega
Patricia Espinosa-González
Erika Palacios-Rosas
Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
Journal of Clinical Medicine
Chagas disease
Chagas cardiomyopathy (CC)
chronic Chagas cardiomyopathy (CCC)
myocarditis
heart failure
title Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
title_full Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
title_fullStr Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
title_full_unstemmed Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
title_short Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
title_sort chagas heart disease beyond a single complication from asymptomatic disease to heart failure
topic Chagas disease
Chagas cardiomyopathy (CC)
chronic Chagas cardiomyopathy (CCC)
myocarditis
heart failure
url https://www.mdpi.com/2077-0383/11/24/7262
work_keys_str_mv AT isisgmontalvoocotoxtle chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT gustavorojasvelasco chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT oliviarodriguezmorales chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT minervaarcefonseca chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT luisabaezaherrera chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT arturoarzateramirez chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT gabrielamelendezramirez chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT danielmanzursandoval chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT mayrallararomero chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT antonioreyesortega chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT patriciaespinosagonzalez chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure
AT erikapalaciosrosas chagasheartdiseasebeyondasinglecomplicationfromasymptomaticdiseasetoheartfailure